These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9605252)

  • 1. Correlation of urine and serum benzoylecgonine levels in pregnant women.
    Monga M; Wong SS; Larrabee KD; Andres RL
    Am J Perinatol; 1997 Nov; 14(10):637-9. PubMed ID: 9605252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry.
    Paul BD; Lalani S; Bosy T; Jacobs AJ; Huestis MA
    Biomed Chromatogr; 2005 Nov; 19(9):677-88. PubMed ID: 15841503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of unique cocaine metabolites and smoking by-products in postmortem blood and urine specimens.
    Jenkins AJ; Goldberger BA
    J Forensic Sci; 1997 Sep; 42(5):824-7. PubMed ID: 9304829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron ionization mass fragmentometric detection of urinary ecgonidine, a hydrolytic product of methylecgonidine, as an indicator of smoking cocaine.
    Paul BD; McWhorter LK; Smith ML
    J Mass Spectrom; 1999 Jun; 34(6):651-60. PubMed ID: 10394630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Cocaine/Crack Biomarkers Concentrations in Oral Fluid, Urine and Plasma Simultaneously Collected From Drug Users.
    Fiorentin TR; Scherer JN; Marcelo MCA; Sousa TRV; Pechansky F; Ferrão MF; Limberger RP
    J Anal Toxicol; 2018 Mar; 42(2):69-76. PubMed ID: 29140478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of fetal cocaine exposure by analysis of amniotic fluid.
    Jain L; Meyer W; Moore C; Tebbett I; Gauthier D; Vidyasagar D
    Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):787-90. PubMed ID: 8469473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified quantitation of urinary benzoylecgonine in cocaine addiction research and for related pharmacotherapeutic trials.
    Peters JE; Chou JZ; Ho A; Reid K; Borg L; Kreek MJ
    Addiction; 1996 Nov; 91(11):1687-97. PubMed ID: 8972926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of cocaine and its major metabolite benzoylecgonine in blood samples from apprehended drivers in Sweden.
    Jones AW; Holmgren A; Kugelberg FC
    Forensic Sci Int; 2008 May; 177(2-3):133-9. PubMed ID: 18164886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of human immunodeficiency virus infection among pregnant crack cocaine users in a rural community.
    Ellerbrock TV; Harrington PE; Bush TJ; Schoenfisch SA; Oxtoby MJ; Witte JJ
    Obstet Gynecol; 1995 Sep; 86(3):400-4. PubMed ID: 7651651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gas chromatographic determination of cocaine and its metabolites in blood and urine from cocaine users in northwestern Spain.
    Fernández P; Buján L; Bermejo AM; Tabernero MJ
    J Appl Toxicol; 2004; 24(4):283-7. PubMed ID: 15300716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine toxicology samples in cocaine treatment trials: how many need to be tested?
    Delucchi KL; Batki SL; Moon J; Jacob P; Jones RT
    J Addict Dis; 2002; 21(2):17-26. PubMed ID: 11916369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crack cocaine: a risk factor for human immunodeficiency virus infection type 1 among inner-city parturients.
    Lindsay MK; Peterson HB; Boring J; Gramling J; Willis S; Klein L
    Obstet Gynecol; 1992 Dec; 80(6):981-4. PubMed ID: 1448268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations.
    Batki SL; Manfredi LB; Jacob P; Jones RT
    J Clin Psychopharmacol; 1993 Aug; 13(4):243-50. PubMed ID: 8376611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of antenatal cocaine use and platelet levels.
    Miller JM; Nolan TE
    Am J Obstet Gynecol; 2001 Feb; 184(3):434-7. PubMed ID: 11228499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preterm premature rupture of the membranes associated with recent cocaine use.
    Delaney DB; Larrabee KD; Monga M
    Am J Perinatol; 1997 May; 14(5):285-8. PubMed ID: 9259945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
    Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
    J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cocaine on fetal kidney and bladder function.
    Mitra SC
    J Matern Fetal Med; 1999; 8(6):262-9. PubMed ID: 10582860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obstetrical and pediatric impact of in utero cocaine exposure].
    Lejeune C; Simonpoli AM; Gressens P
    Arch Pediatr; 2009 Sep; 16 Suppl 1():S56-63. PubMed ID: 19836669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of fluconazole interference in gas chromatography/mass spectrometric confirmation of benzoylecgonine, the major metabolite of cocaine using pentafluoropropionyl derivative.
    Dasgupta A; Mahle C; McLemore J
    J Forensic Sci; 1996 May; 41(3):511-3. PubMed ID: 8656195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An automated preconcentration-derivatization system for the determination of cocaine and its metabolites in urine and illicit cocaine samples by gas chromatography/mass spectrometry.
    Cardenas S; Gallego M; Valcarcel M
    Rapid Commun Mass Spectrom; 1996; 10(6):631-6. PubMed ID: 8624416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.